Public court records · Regulatory sources · Independently maintained Data as of: 2026-10-21 · Not legal advice

GLP-1 NAION (Semaglutide Vision Loss) (US): Settlement Amounts

MDL Consolidated

United States case record · Last verified:

Reported amounts & case results

No global settlement as of the Oct 21 2026 check. The JPML report of Oct 1, 2026 lists 247 pending actions in MDL 3163 (per JPML). Individual case values are not public; per claimant reports, early matters remain in discovery. Any figures published by firms are illustrative, not promised.

Figures are as reported by the cited sources — not a promise of any individual outcome.

Reported amounts are what sources say — not a promise. Individual results depend on injuries, jurisdiction, and the stage of the case. This is not legal advice.

What affects case value

  • Injury severity — the single largest driver across mass torts.
  • Jurisdiction — national/state/provincial law (e.g., discovery rules, statute of limitations) can change outcomes.
  • Case stage — early filings and post-bellwether values differ.
  • Documentation — medical records and the exposure timeline.

Estimate your situation

See whether your case compares to documented outcomes. Free, no obligation.

Start free case review →